{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:51:42Z","timestamp":1778795502721,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,5]]},"DOI":"10.7759\/cureus.80101","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T21:30:36Z","timestamp":1741210236000},"source":"Crossref","is-referenced-by-count":1,"title":["Giant Uterine Tumor Compatible With Sarcoma"],"prefix":"10.7759","author":[{"given":"Elias","family":"Gallardo-Navarro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Saad Ganem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana Margarita","family":"Acosta Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Muradas Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco M","family":"Garcia Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000443","article-title":"Incidence and survival of gynecologic sarcomas in England","volume":"25","author":"Francis M","year":"2015","unstructured":"Francis M, Dennis NL, Hirschowitz L, Grimer R, Poole J, Lawrence G, Nordin A. Incidence and survival of gynecologic sarcomas in England. Int J Gynecol Cancer. 2015, 25:850-7. 10.1097\/IGC.0000000000000443","journal-title":"Int J Gynecol Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.87011","article-title":"Clinical outcome of patients with uterine sarcomas","volume":"7","author":"Sharma DN","year":"2011","unstructured":"Sharma DN, Rath GK, Kumar S, Kumar L, Bhatla N, Gandhi AK, Hariprasad R. Clinical outcome of patients with uterine sarcomas. J Cancer Res Ther. 2011, 7:270-4. 10.4103\/0973-1482.87011","journal-title":"J Cancer Res Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000494335","article-title":"Uterine carcinosarcomas - diagnosis and management","volume":"41","author":"Denschlag D","year":"2018","unstructured":"Denschlag D, Ulrich UA. Uterine carcinosarcomas - diagnosis and management. Oncol Res Treat. 2018, 41:675-9. 10.1159\/000494335","journal-title":"Oncol Res Treat"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000911","article-title":"European Society of Gynecological Oncology statement on fibroid and uterine morcellation","volume":"27","author":"Halaska MJ","year":"2017","unstructured":"Halaska MJ, Haidopoulos D, Guyon F, Morice P, Zapardiel I, Kesic V. European Society of Gynecological Oncology statement on fibroid and uterine morcellation. Int J Gynecol Cancer. 2017, 27:189-92. 10.1097\/IGC.0000000000000911","journal-title":"Int J Gynecol Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.15557\/JoU.2022.0017","article-title":"Uterine Myomas and sarcomas - clinical and ultrasound characteristics and differential diagnosis using pulsed and color Doppler techniques","volume":"22","author":"Wojtowicz K","year":"2022","unstructured":"Wojtowicz K, G\u00f3ra T, Guzik P, Harpula M, Chechli\u0144ski P, Wolak E, Stryjkowska-G\u00f3ra A. Uterine Myomas and sarcomas - clinical and ultrasound characteristics and differential diagnosis using pulsed and color Doppler techniques. J Ultrason. 2022, 22:100-8. 10.15557\/JoU.2022.0017","journal-title":"J Ultrason"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231157645","article-title":"Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)","volume":"15","author":"P\u00e9rez-Fidalgo JA","year":"2023","unstructured":"P\u00e9rez-Fidalgo JA, Ortega E, Ponce J, et al.. Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS). Ther Adv Med Oncol. 2023, 15:17588359231157645. 10.1177\/17588359231157645","journal-title":"Ther Adv Med Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.29193\/rmu.39.2.9","article-title":"Sarcoma uterino de topograf\u00eda cervical","volume":"39","author":"Nozar F","year":"2023","unstructured":"Nozar F, Tarigo J, Greif D, Ben S. Sarcoma uterino de topograf\u00eda cervical. Rev M\u00e9d Urug. 2023, 39:10.29193\/rmu.39.2.9","journal-title":"Rev M\u00e9d Urug"},{"key":"ref8","article-title":"Sarcoma uterino. Reporte de caso","volume":"80","author":"Mortara-G\u00f3mez AS","year":"2012","unstructured":"Mortara-G\u00f3mez AS, Blanco RG, Arias-Loza R, Sangines- Mart\u00ednez A, Moreno-Lara HJM, Zertuche-Zuani JG. Sarcoma uterino. Reporte de caso. Ginecol Obstet Mex. 2012, 80:224-7.","journal-title":"Ginecol Obstet Mex"},{"key":"ref9","article-title":"Sarcoma uterino: revisi\u00f3n de la literatura","volume":"11","author":"Mart\u00ednez-Madrigal M","year":"2012","unstructured":"Mart\u00ednez-Madrigal M, Mu\u00f1oz-Gonz\u00e1lez DE, Ochoa-Carrillo FJ, Camacho-Beiza IR, Garc\u00eda-Ju\u00e1rez E, Flores-Manzur A. Sarcoma uterino: revisi\u00f3n de la literatura. Gaceta Mexicana de Oncolog\u00eda. 2012, 11:113-7.","journal-title":"Gaceta Mexicana de Oncolog\u00eda"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2017.02.006","article-title":"Uterine sarcoma with ambiguous histomorphology: a case report","volume":"20","author":"Miller EM","year":"2017","unstructured":"Miller EM, Fu Y, Vera RB, Goldberg GL, Karabakhtsian RG. Uterine sarcoma with ambiguous histomorphology: a case report. Gynecol Oncol Rep. 2017, 20:30-3. 10.1016\/j.gore.2017.02.006","journal-title":"Gynecol Oncol Rep"},{"key":"ref11","unstructured":"Dataset for histological reporting of uterine sarcomas. (2014). Accessed. June 19, 2015: https:\/\/www.rcpath.org\/Resources\/RCPath\/Migrated%2520 Resources\/Documents\/G\/G106_UterineSarcomaDataset_Dec14.pdf."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2014.07.018","article-title":"Incidental gynecologic neoplasms in morcellated uterine specimens: a case series with follow-up","volume":"45","author":"Ehdaivand S","year":"2014","unstructured":"Ehdaivand S, Simon RA, Sung CJ, Steinhoff MM, Lawrence WD, Quddus MR. Incidental gynecologic neoplasms in morcellated uterine specimens: a case series with follow-up. Hum Pathol. 2014, 45:2311-7. 10.1016\/j.humpath.2014.07.018","journal-title":"Hum Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-0864-5","article-title":"Circulating transcripts and biomarkers in uterine tumors: is there a predictive role?","volume":"22","author":"De Bruyn C","year":"2020","unstructured":"De Bruyn C, Baert T, Van den Bosch T, Coosemans A. Circulating transcripts and biomarkers in uterine tumors: is there a predictive role?. Curr Oncol Rep. 2020, 22:12. 10.1007\/s11912-020-0864-5","journal-title":"Curr Oncol Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13553","article-title":"Circulating protein biomarkers to differentiate uterine sarcomas from leiomyomas","volume":"39","author":"Glorie N","year":"2019","unstructured":"Glorie N, Baert T, VA VA Bosch T, Coosemans AN. Circulating protein biomarkers to differentiate uterine sarcomas from leiomyomas. Anticancer Res. 2019, 39:3981-9. 10.21873\/anticanres.13553","journal-title":"Anticancer Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153825","article-title":"Liquid biopsy as a tool for differentiation of leiomyomas and sarcomas of corpus uteri","volume":"20","author":"Dvorsk\u00e1 D","year":"2019","unstructured":"Dvorsk\u00e1 D, \u0160kovierov\u00e1 H, Bran\u00fd D, Hala\u0161ov\u00e1 E, Dankov\u00e1 Z. Liquid biopsy as a tool for differentiation of leiomyomas and sarcomas of corpus uteri. Int J Mol Sci. 2019, 20:3825. 10.3390\/ijms20153825","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)91298-q","article-title":"Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas","volume":"162","author":"Leibsohn S","year":"1990","unstructured":"Leibsohn S, d\u2019Ablaing G, Mishell DR, Schlaerth JB. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstetr Gynecol. 1990, 162:968-76. 10.1016\/0002-9378(90)91298-q","journal-title":"Am J Obstetr Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.02.012","article-title":"Prognosis and treatment of uterine leiomyosarcoma: a National Cancer Database study","volume":"145","author":"Seagle BL","year":"2017","unstructured":"Seagle BL, Sobecki-Rausch J, Strohl AE, Shilpi A, Grace A, Shahabi S. Prognosis and treatment of uterine leiomyosarcoma: a National Cancer Database study. Gynecol Oncol. 2017, 145:61-70. 10.1016\/j.ygyno.2017.02.012","journal-title":"Gynecol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/a-0882-4116","article-title":"Sarcoma of the uterus. Guideline of the DGGG and OEGGG (S2K level, AWMF Register Number 015\/074, February 2019)","volume":"79","author":"Denschlag D","year":"2019","unstructured":"Denschlag D, Ackermann S, Battista MJ, et al.. Sarcoma of the uterus. Guideline of the DGGG and OEGGG (S2K level, AWMF Register Number 015\/074, February 2019). Geburtshilfe Frauenheilkd. 2019, 79:1043-60. 10.1055\/a-0882-4116","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/0976-7800.145175","article-title":"Uterine leiomyosarcoma: a case report","volume":"5","author":"Kaur P","year":"2014","unstructured":"Kaur P, Kaur A, Singla A, Kaur K. Uterine leiomyosarcoma: a case report. J Mid-life Health. 2014, 5:200. 10.4103\/0976-7800.145175","journal-title":"J Mid-life Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-015-0433-9","article-title":"","volume":"6","author":"Sivakumari S","year":"2015","unstructured":"Sivakumari S, Rajaraman R. Subbiah S.Indian J Surg Oncol. 2015, 6:232-6. 10.1007\/s13193-015-0433-9","journal-title":"Subbiah S.Indian J Surg Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001055","article-title":"NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma","volume":"42","author":"Chiang S","year":"2018","unstructured":"Chiang S, Cotzia P, Hyman DM, et al.. NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma. Am J Surg Pathol. 2018, 42:791-8. 10.1097\/PAS.0000000000001055","journal-title":"Am J Surg Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/341848-giant-uterine-tumor-compatible-with-sarcoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T21:30:38Z","timestamp":1741210238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/341848-giant-uterine-tumor-compatible-with-sarcoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.80101","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,5]]}}}